G. Oteri

1.4k total citations
32 papers, 1.0k citations indexed

About

G. Oteri is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, G. Oteri has authored 32 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 25 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in G. Oteri's work include Epilepsy research and treatment (25 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Drug Transport and Resistance Mechanisms (5 papers). G. Oteri is often cited by papers focused on Epilepsy research and treatment (25 papers), Pharmacological Effects and Toxicity Studies (25 papers) and Drug Transport and Resistance Mechanisms (5 papers). G. Oteri collaborates with scholars based in Italy, United Kingdom and Sweden. G. Oteri's co-authors include Francesco Pisani, R. Di Perri, Cinzia Costa, Emilio Perucca, Giorgio Di Raimondo, Marco Russo, A. Fazio, F Pisani, Edoardo Spina and A. Richens and has published in prestigious journals such as Journal of Neurology Neurosurgery & Psychiatry, Experimental Brain Research and Experimental Neurology.

In The Last Decade

G. Oteri

32 papers receiving 997 citations

Peers

G. Oteri
Lennart Gram Denmark
J. W. A. Meijer Netherlands
PN Patsalos United Kingdom
N. Callaghan Ireland
M.J. Brodie United Kingdom
Ronald C. Reed United States
A A Miller United Kingdom
Gerard Forrest United Kingdom
Lennart Gram Denmark
G. Oteri
Citations per year, relative to G. Oteri G. Oteri (= 1×) peers Lennart Gram

Countries citing papers authored by G. Oteri

Since Specialization
Citations

This map shows the geographic impact of G. Oteri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Oteri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Oteri more than expected).

Fields of papers citing papers by G. Oteri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Oteri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Oteri. The network helps show where G. Oteri may publish in the future.

Co-authorship network of co-authors of G. Oteri

This figure shows the co-authorship network connecting the top 25 collaborators of G. Oteri. A scholar is included among the top collaborators of G. Oteri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Oteri. G. Oteri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gorgone, Gaetano, Daniela Caccamo, Laura Rosa Pisani, et al.. (2009). Hyperhomocysteinemia in patients with epilepsy: Does it play a role in the pathogenesis of brain atrophy? A preliminary report. Epilepsia. 50(s1). 33–36. 34 indexed citations
2.
Belcastro, Vincenzo, Pasquale Striano, Gaetano Gorgone, et al.. (2009). Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia. 51(2). 274–279. 81 indexed citations
3.
Pisani, Francesco, et al.. (2009). Effects of the antidepressant drug viloxazine on oxcarbazepine and its hydroxylated metabolites in patients with epilepsy. Acta Neurologica Scandinavica. 90(2). 130–132. 5 indexed citations
4.
Belcastro, Vincenzo, Domenico Italiano, G. Oteri, et al.. (2007). Antiepileptic Drugs and MTHFR Polymorphisms Influence Hyper‐Homocysteinemia Recurrence in Epileptic Patients. Epilepsia. 48(10). 1990–1994. 40 indexed citations
5.
Pisani, Francesco, Cinzia Costa, Daniela Caccamo, et al.. (2006). Tiagabine and vigabatrin reduce the severity of NMDA-induced excitotoxicity in chick retina. Experimental Brain Research. 171(4). 511–515. 6 indexed citations
6.
Pisani, Francesco, Vincenzo Macaione, Valerio Torre, et al.. (2001). Neuroprotective Effects of Lamotrigine and Remacemide on Excitotoxicity Induced by Glutamate Agonists in Isolated Chick Retina. Experimental Neurology. 170(1). 162–170. 15 indexed citations
7.
Pisani, F, Edoardo Spina, & G. Oteri. (1999). Antidepressant Drugs and Seizure Susceptibility: From In Vitro Data to Clinical Practice. Epilepsia. 40(s10). S48–56. 81 indexed citations
8.
Pisani, Francesco, G. Oteri, Marco Russo, et al.. (1999). The Efficacy of Valproate‐Lamotrigine Comedication in Refractory Complex Partial Seizures: Evidence for a Pharmacodynamic Interaction. Epilepsia. 40(8). 1141–1146. 183 indexed citations
9.
Oteri, G., Flavia Zucco, & Annalaura Stammati. (1998). Cytoskeleton perturbations induced by okadaic acid in two human cell lines. Toxicology Letters. 95. 151–152. 1 indexed citations
10.
Pisani, F, Abdulla Haj-Yehia, A. Fazio, et al.. (1993). Carbamazepine‐Valnoctamide Interaction in Epileptic Patients: In Vitro/In Vivo Correlation. Epilepsia. 34(5). 954–959. 21 indexed citations
11.
Fazio, A., et al.. (1992). A Liquid Chromatographic Assay Using a High-Speed Column for the Determination of Lamotrigine, a New Antiepileptic Drug, in Human Plasma. Therapeutic Drug Monitoring. 14(6). 509–512. 46 indexed citations
12.
Pisani, Francesco, Marco Caputo, A. Fazio, et al.. (1990). Interaction of Carbamazepine‐10,11‐Epoxide, an Active Metabolite of Carbamazepine, with Valproate: A Pharmacokinetic Study. Epilepsia. 31(3). 339–342. 23 indexed citations
13.
Spina, Edoardo, et al.. (1990). No Effect of Thioridazine on Plasma Concentrations of Carbamazepine and Its Active Metabolite Carbamazepine-10,11-Epoxide. Therapeutic Drug Monitoring. 12(5). 511–513. 2 indexed citations
14.
Perucca, Emilio, Francesco Pisani, Edoardo Spina, et al.. (1989). Effects of valpromide and viloxazine on the elimination of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. Pharmacological Research. 21(1). 111–112. 3 indexed citations
15.
Pisani, Francesco, A. Fazio, G. Oteri, et al.. (1987). An epidemiological study of the clinical impact of pharmacokinetic anticonvulsant drug interactions based on serum drug level analysis. The Italian Journal of Neurological Sciences. 8(2). 135–141. 5 indexed citations
16.
Pisani, Francesco, et al.. (1987). Prevalence of epilepsy in children of Reggio Calabria, southern Italy.. PubMed. 9(1). 40–3. 3 indexed citations
17.
Pisani, Francesco, et al.. (1986). Sodium Valproate and Valpromide: Differential Interactions with Carbamazepine in Epileptic Patients. Epilepsia. 27(5). 548–552. 41 indexed citations
18.
Pisani, F, et al.. (1984). Valproic Acid‐Ethosuximide Interaction: A Pharmacokinetic Study. Epilepsia. 25(2). 229–233. 28 indexed citations
19.
Pisani, Francesco, A. Fazio, G. Oteri, & R. Di Perri. (1982). A study on the metabolism of dipropylacetamide to dipropylacetic acid in rats. Journal of Pharmacy and Pharmacology. 34(1). 45–46. 14 indexed citations
20.
Pisani, Francesco, G. Oteri, & R. Di Perri. (1981). Valproic acid fails to displace phenobarbitone and carbamazepine from plasma protein binding sites in epileptic patients.. British Journal of Clinical Pharmacology. 12(1). 81–83. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026